Product Information
SIMPONI 100 MG/ML PEN INJECTOR is a brand product labeled by Janssen Biotech, Inc., priced at $7446.2126 per ML under NDC 57894007102. Its NADAC has been published 78 times since Sep 18, 2024.
Strength
100 mg/mL
Manufacturer
Janssen Biotech, Inc.NDC
57894007102
Classification
Brand
Dosage Form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Effective Date
1/2/2026
Active Ingredients
GOLIMUMABApproval Type
Biologic (BLA)
FDA Application
BLA125289On Market Since
5/15/2013
Pharmacological Classes
Price Statistics
The NADAC for SIMPONI 100 MG/ML PEN INJECTOR has been published 78 times since Sep 18, 2024, and over the history we have for it it has risen 9.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $7446.2126 per ML |
|---|---|
| All-time high | $7446.2126 (Mar 11, 2026) |
| All-time low | $6818.8760 (Sep 18, 2024) |
| 52-week high | $7446.2126 |
| 52-week low | $7091.6310 |
| Median price | $7091.6310 |
| Average price | $7073.0977 |
| Largest weekly change | +5.0% (Jan 14, 2026) |
| Weeks tracked | 78 |
| Tracking since | Sep 18, 2024 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
+5.0%
3Y
N/A
5Y
N/A
All
+9.2%
Last surveyed Mar 11, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the golimumab market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Janssen Biotech, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
golimumab market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Tumor Necrosis Factor Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of SIMPONI 100 MG/ML PEN INJECTOR?
The current National Average Drug Acquisition Cost (NADAC) for SIMPONI 100 MG/ML PEN INJECTOR, manufactured by Janssen Biotech, Inc., is $7446.2126 per ML (NDC 57894007102), effective Mar 11, 2026.
How has the price of SIMPONI 100 MG/ML PEN INJECTOR changed over time?
Over the history we have for it, the NADAC for SIMPONI 100 MG/ML PEN INJECTOR has risen 9.2%. It has been tracked across 78 weekly CMS publications since Sep 18, 2024.
What are the highest and lowest recorded NADAC prices for SIMPONI 100 MG/ML PEN INJECTOR?
Since Sep 18, 2024, the NADAC for SIMPONI 100 MG/ML PEN INJECTOR has ranged from a low of $6818.8760 (Sep 18, 2024) to a high of $7446.2126 (Mar 11, 2026), with a median of $7091.6310 per ML.
Are there cheaper alternatives to SIMPONI 100 MG/ML PEN INJECTOR?
No other NADAC-published product currently shares the active ingredient and strength of SIMPONI 100 MG/ML PEN INJECTOR in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures SIMPONI 100 MG/ML PEN INJECTOR?
SIMPONI 100 MG/ML PEN INJECTOR (NDC 57894007102) is labeled by Janssen Biotech, Inc., and CMS classifies it as a brand product.